VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is the first to demonstrate the isolation and analysis of >99% pure circulating tumor-derived DNA (ctDNA).
Abstract: Today's ultrasonic flow metering is very important in the industry. By using ultrasound tomography, we can be obtained cross-sectional images from inside a tube that contains two-phase fluid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results